Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Clascoterone and Nandrolone Interaction: Monitor | Peptide Database

Compound Profiles Clascoterone Topical Androgen Receptor Inhibitor | Acne & Hair Loss Clascoterone acts as a competitive antagonist of the androgen receptor (AR). When applied topically, it penetrates the skin and binds directly to androgen receptors in target

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Clascoterone

Topical Androgen Receptor Inhibitor | Acne & Hair Loss

Clascoterone acts as a competitive antagonist of the androgen receptor (AR). When applied topically, it penetrates the skin and binds directly to androgen receptors in target tissues -- sebaceous glands (for acne) and dermal papilla cells of hair follicles (for alopecia).

Nandrolone

Anabolic-Androgenic Steroid | Joint & Collagen Support

Nandrolone binds to the androgen receptor (AR) with affinity comparable to testosterone, promoting nitrogen retention, protein synthesis, and satellite cell activation in skeletal muscle tissue. Its anabolic effects are mediated through AR-dependent gene transcription that upregulates muscle-specific proteins including myosin heavy chain and IGF-1.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Clascoterone with Nandrolone?

Yes, but with caution. Both Clascoterone and Nandrolone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. Regular monitoring is advised.

Is Clascoterone and Nandrolone safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: androgenic, teratogenic. Monitor accordingly.

What are the interactions between Clascoterone and Nandrolone?

Both Clascoterone and Nandrolone carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. This assessment has 60% confidence and is inferred from pharmacological mechanism analysis.

How should I time Clascoterone and Nandrolone?

Clascoterone has a half-life of Short topical (local action; rapidly metabolized to cortexolone) and Nandrolone has a half-life of ~6-12 days (decanoate). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

PNC-27 shows selective cytotoxicity against pancreatic cancer cells in research. Demonstrated effectiveness against breast cancer cell lines. Induces necrosis of K-562 leukemia cells through HDM-2 binding. Shows selective targeting of melanoma cells. Most effective against cancers with high membrane HDM-2 expression. Model compound for studying cancer-selective therapies.

Source: peptide-db.com ↗

Research Indications

Stimulates thymocyte proliferation and enlarges thymic lobules. Activates T-helper cells and improves immune response. Restores chromatin structure and gene expression in aged lymphocytes. Long-term treatment increased mean lifespan 20-40% in rodent studies. Suppresses development of spontaneous and induced tumors. Promotes recovery in tissues exposed to radiation damage. Restores brush border membrane enzyme levels in aged animals. Enhances intestinal barrier function in aged rats.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

How-to reference

How to Stack Them

A practical approach based on evidence tiers: Foundation (everyone): CoQ10 100-300mg daily (especially if on statins or over 50) Creatine 3-5g daily Second layer (longevity-focused): NMN 250-500mg or NR 300mg daily Urolithin A 500-1000mg daily Research tier (advanced, with medical oversight): NAD+ IV 250-500mg weekly or SubQ 100-500mg 2-3x weekly SS-31 5-10mg daily SubQ MOTS-c 5-10mg daily SubQ (WADA prohibited) Check interactions between any peptides in your stack: Interaction checker Use our cost calculator to work out per-dose pricing.

Source: peptide-db.com ↗
Dosage reference

Dosing Protocols

Nandrolone is administered exclusively via intramuscular injection. Two ester formulations are available: nandrolone decanoate (Deca-Durabolin), a long-acting ester that permits weekly or biweekly dosing, and nandrolone phenylpropionate (NPP), a shorter ester requiring injections every 2-3 days. Decanoate is more common in clinical and performance settings due to its convenient dosing schedule, while NPP is preferred by those who want faster clearance and more rapid dose adjustments. TRT Adjunct - Joint Support 50-100 mg/week 1x per week (decanoate) Intramuscular Therapeutic - Anemia / Wasting 100-200 mg/week Performance Enhancement - Moderate 200-400 mg/week 1x per week (decanoate) or split into 2 injections NPP Protocol - Shorter Cycle 200-350 mg/week Every other day or 3x per week

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →